wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41207230-1CB0AEE6-168B-42C6-9D8F-C6F423DCAC2A
Q41207230-1CB0AEE6-168B-42C6-9D8F-C6F423DCAC2A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41207230-1CB0AEE6-168B-42C6-9D8F-C6F423DCAC2A
The cost-effectiveness, health benefits, and financial costs of new antiviral treatments for hepatitis C virus.
P2860
Q41207230-1CB0AEE6-168B-42C6-9D8F-C6F423DCAC2A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41207230-1CB0AEE6-168B-42C6-9D8F-C6F423DCAC2A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b12cedf88eeefe333be71600f1c5363b979ec562
P2860
Treatment rates in patients with chronic hepatitis C after liver biopsy.